Financhill
Sell
30

LULU Quote, Financials, Valuation and Earnings

Last price:
$279.61
Seasonality move :
12.31%
Day range:
$280.83 - $291.76
52-week range:
$226.01 - $423.32
Dividend yield:
0%
P/E ratio:
19.26x
P/S ratio:
3.31x
P/B ratio:
7.90x
Volume:
4.4M
Avg. volume:
2.2M
1-year change:
-27.54%
Market cap:
$34.1B
Revenue:
$10.6B
EPS (TTM):
$14.70

Earnings Data

Next earnings date for LULU
Jun 05
2025
Most recent earnings per share
$6.14
Beat by $0.27
(Mar 27/2025)
Consensus Estimate
$5.87
(Mar 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LULU Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/05/2025 Q2 $2.4B -- -- $2.59 --
03/27/2025 Q1 $3.6B $3.6B $6.14 $5.87 $0.27
12/05/2024 Q4 $2.4B $2.4B $2.87 $2.72 $0.15
08/29/2024 Q3 $2.4B $2.4B $3.15 $2.94 $0.21
06/05/2024 Q2 $2.2B $2.2B $2.54 $2.40 $0.14
03/21/2024 Q1 $3.2B $3.2B $5.28 $5.01 $0.27
12/07/2023 Q4 -- -- $1.96 $2.28 -$0.32
08/31/2023 Q3 -- -- $2.68 $2.54 $0.14
06/01/2023 Q2 -- -- $2.28 $1.98 $0.30
03/28/2023 Q1 -- -- $0.94 $4.26 -$3.32
12/08/2022 Q4 -- -- $2.00 $1.96 $0.04
09/01/2022 Q3 -- -- $2.26 $1.86 $0.40
06/02/2022 Q2 -- -- $1.48 $1.43 $0.05
03/29/2022 Q1 -- -- $3.36 $3.27 $0.09
12/09/2021 Q4 -- -- $1.44 $1.40 $0.04
09/08/2021 Q3 -- -- $1.59 $1.19 $0.40
06/03/2021 Q2 -- -- $1.11 $0.91 $0.20
03/30/2021 Q1 -- -- $2.52 $2.49 $0.03
12/10/2020 Q4 -- -- $1.10 $0.88 $0.22
09/08/2020 Q3 -- -- $0.66 $0.56 $0.10
06/11/2020 Q2 -- -- $0.22 $0.27 -$0.05
03/26/2020 Q1 -- -- $2.28 $2.25 $0.03
12/11/2019 Q4 -- -- $0.96 $0.93 $0.03
09/05/2019 Q3 -- -- $0.96 $0.89 $0.07
06/12/2019 Q2 -- -- $0.74 -- --
03/27/2019 Q1 -- -- $1.65 -- --
12/05/2018 Q4 -- -- $0.71 -- --
08/30/2018 Q3 -- -- $0.71 -- --
05/31/2018 Q2 -- -- $0.55 -- --
03/27/2018 Q1 -- -- $0.88 -- --
12/06/2017 Q4 -- -- $0.43 -- --
08/31/2017 Q3 -- -- $0.36 -- --
06/01/2017 Q2 -- -- $0.23 -- --
03/29/2017 Q1 -- -- $0.99 -- --
12/07/2016 Q4 -- -- $0.50 -- --
09/01/2016 Q3 -- -- $0.39 -- --
06/08/2016 Q2 -- -- $0.33 -- --
03/30/2016 Q1 -- -- $0.85 -- --
12/09/2015 Q4 -- -- $0.38 -- --
09/10/2015 Q3 -- -- $0.34 -- --
06/09/2015 Q2 -- -- $0.34 -- --

Lululemon Athletica Earnings Questions

  • How Much did Lululemon Athletica Generate in Revenue Last Quarter?

    Lululemon Athletica reported $3.6B worth of top line sales in its most recent quarter.

  • Did Lululemon Athletica Beat Earnings Last Quarter?

    Lululemon Athletica announced earnings per share of $6.14 which represents a beat of analyst forecast a $5.87 per share.

  • Is Lululemon Athletica Profitable?

    Lululemon Athletica reported $2.2B that represents $17.92 per share over the last quarter.

  • What is the Analyst Consensus for Lululemon Athletica EPS Next Year?

    Lululemon Athletica's earnings are forecast to grow from $14.64 per share to $14.38 per share next year representing an increase of 4.15%.

  • When is Lululemon Athletica's Earnings Date?

    Lululemon Athletica's next earnings date is June 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 19.56% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 14.62% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 4.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock